Cell persistence and senescence are distinct states of proliferative arrest induced by cancer therapy, with persister cells being characterized by the silencing of inflammatory genes through the heterochromatic mark H4K20me3.
Discover emerging themes and early-stage clinical oncology pipelines at the second AACR Oncology Industry Partnership event.
This cohort study examines the response and survival rates associated with ipilimumab-nivolumab therapy in patients with progressive melanoma brain metastases after anti–programmed cell death 1…
Can pollution cause it? What about inflammation? And how do tumors spread? Here’s what scientists are learning about this complex disease.
China’s NMPA approved isatuximab plus VRd for newly diagnosed, transplant-ineligible multiple myeloma.
The EMA’s CHMP has recommended the approval of liso-cel for relapsed/refractory follicular lymphoma after at least 2 prior lines of therapy.
Nature Reviews Cancer – In this study, Alexander et al. find that HIF2α regulates speckle–DNA associations to fine-tune the expression of a subset of its…
Slow intravenous (iv) hydromorphone infusion resulted in similar abuse liability potential and pain improvement but less sedation than fast injection. These findings, taken together, suggest…
SAN DIEGO — Insurers rejected one-third of new prescriptions for specialty oral anticancer medications ordered for patients with blood cancers, according to retrospective data presented…
CA: A Cancer Journal for Clinicians is ACS’ flagship clinical oncology journal publishing information about the prevention, early detection, and treatment of cancer.
In this special collection of the Journal of Neuro-Oncology, we provide a comprehensive overview of recent advances in surgical resection of HGGs as well as…
